Lensar (LNSR) Net Cash Flow (2019 - 2026)
Lensar's (LNSR) quarterly Net Cash Flow came in at -$480000.0 in Q1 2026, down 114.62% year-on-year from $3.3 million in Q1 2025, and down 108.99% on a QoQ basis from $5.3 million in Q4 2025.
Lensar (LNSR) Net Cash Flow (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Net Cash Flow data on file, last reported at -$480000.0 in Q1 2026.
- On a quarterly basis, Net Cash Flow fell 114.62% year-over-year to -$480000.0 in Q1 2026; TTM through Mar 2026 was -$7.1 million, a 226.19% decrease from a year earlier, with the FY2025 full-year figure at -$3.3 million, up 24.53% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$480000.0, down from $5.3 million in the prior quarter.
- Over the last five years, Net Cash Flow for LNSR reached as high as $5.8 million in Q4 2024 and fell as low as -$12.4 million in Q2 2025.
- Historically, Net Cash Flow has averaged -$2.2 million across 5 years, with a median of -$2.7 million in 2022.
- Across the five-year window, Net Cash Flow slumped 556.11% in 2022 and jumped 494.69% in 2024, its largest moves.
- Year by year, Net Cash Flow stood at -$4.6 million in 2022, then climbed by 6.93% to -$4.3 million in 2023, then surged by 235.4% to $5.8 million in 2024, then decreased by 8.31% to $5.3 million in 2025, then sank by 108.99% to -$480000.0 in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were -$480000.0 in Q1 2026, $5.3 million in Q4 2025, and $487000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lensar | 70.05 Mn | 72.73 Mn | 6.38 Mn | -480,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -480,000.00 |
| Mar 31, 2026 | -480,000.00 |
| Dec 31, 2025 | 5.34 Mn |
| Dec 31, 2025 | 5.34 Mn |
| Sep 30, 2025 | 487,000.00 |
| Sep 30, 2025 | 487,000.00 |
| Jun 30, 2025 | -12.40 Mn |
| Jun 30, 2025 | -12.40 Mn |
| Mar 31, 2025 | 3.28 Mn |
| Mar 31, 2025 | 3.28 Mn |
| Dec 31, 2024 | 5.82 Mn |
| Dec 31, 2024 | 5.82 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | -5.67 Mn |
| Jun 30, 2024 | -5.67 Mn |
| Mar 31, 2024 | -6.66 Mn |
| Mar 31, 2024 | -6.66 Mn |
| Dec 31, 2023 | -4.30 Mn |
| Dec 31, 2023 | -4.30 Mn |